Background Annually, 4% of the global population undergoes non-cardiac surgery, with 30% of those patients having at least ...
Background Ebstein’s anomaly (EA) exhibits significant anatomical and clinical heterogeneity, warranting a systematic ...
Objective To evaluate the potential mediating role of left ventricular ejection fraction (LVEF) in the relationship between replacement fibrosis (assessed by late gadolinium enhancement (LGE)) and ...
Background Ruling out myocardial infarction (MI) in patients with an initial indeterminate (detectable to mildly elevated) troponin measure is challenging. Myocardial-Ischaemic-Injury Index (MI 3) is ...
Objective Most current cardiovascular disease (CVD) risk stratification tools are for people without CVD, but very few are for prevalent CVD. In this study, we developed and validated a CVD severity ...
Background The epidemiology of native valve infective endocarditis (IE) has shifted toward older adults with substantial comorbidity burdens, yet contemporary nationwide data on outcomes and surgical ...
Background Multiple long-term conditions (MLTCs) are common among individuals with heart failure (HF); however, the influence of sex on clinical characteristics and prognosis remains unclear. This ...
Background Amyloid transthyretin (ATTR) amyloidosis is a rare, life-threatening disease frequently manifesting with cardiomyopathy (ATTR-CM), polyneuropathy (ATTR-PN) or both (ATTR-mixed). We ...
Contemporary cardiology faces a paradox: unprecedented technological capability coincides with declining scientific curiosity and clinical judgement. This manuscript examines the shift from ...
Introduction Worldwide, an estimated 37 million people have a diagnosis of heart failure. 1 2 The lifetime risk for developing heart failure is approximately 20%. 3 The prevalence of heart failure is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback